262 related articles for article (PubMed ID: 12069452)
1. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
Ceconi C; Ferrari R; Bachetti T; Opasich C; Volterrani M; Colombo B; Parrinello G; Corti A
Eur Heart J; 2002 Jun; 23(12):967-74. PubMed ID: 12069452
[TBL] [Abstract][Full Text] [Related]
2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
3. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
8. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
9. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
[TBL] [Abstract][Full Text] [Related]
10. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.
Stanton EB; Hansen MS; Sole MJ; Gawad Y; Packer M; Pitt B; Swedberg K; Rouleau JL;
Can J Cardiol; 2005 Jan; 21(1):39-43. PubMed ID: 15685301
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
[TBL] [Abstract][Full Text] [Related]
12. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
[TBL] [Abstract][Full Text] [Related]
14. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
15. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
[TBL] [Abstract][Full Text] [Related]
17. Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.
Majani G; Pierobon A; Pinna GD; Giardini A; Maestri R; La Rovere MT
Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):836-42. PubMed ID: 21450593
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
[TBL] [Abstract][Full Text] [Related]
19. Plasma bradykinin levels in human chronic congestive heart failure.
Cugno M; Agostoni P; Brunner HR; Gardinali M; Agostoni A; Nussberger J
Clin Sci (Lond); 2000 Nov; 99(5):461-6. PubMed ID: 11052927
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the QRS duration in patients with heart failure: a subgroup analysis from 24 centers of Val-HeFT.
Hofmann M; Bauer R; Handrock R; Weidinger G; Goedel-Meinen L
J Card Fail; 2005 Sep; 11(7):523-8. PubMed ID: 16198248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
